0
Skip to Content
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
About Us
English
DONATE
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
About Us
English
DONATE
For Patients
For Researchers
For Clinicians
Take Action
About Us
English
Back
DONATE
  • Medical Education Webinars,
  • Patient Videos & Webinars,
• 8/7/24

2021 RUNX1 Week Keynote Speaker: Dr. David Fajgenbaum

Dr. David Fajgenbaum, co-founder and CEO of the Castleman Disease Collaborative Network, discusses his personal battle with this rare disease that almost killed him several times, and his tireless research that led to the discovery of a life-saving treatment for himself and many other Castleman patients.

Previous

Crosstalk Between Transcription Factors, Methyltransferases and Tyrosine Kinases

Next

Inherited Thrombocytopenia (ITP): What Is It, Whom To Test and How To Test?

You Might Also Like

Related Embedded Video Item Thumbnail Crosstalk Between Transcription Factors, Methyltransferases and Tyrosine Kinases
Related Embedded Video Item Thumbnail RRP Patient Meeting 2023: Upcoming Clinical Studies - Dr. Alan Cantor and Dr. Lea Cunningham
Related Embedded Video Item Thumbnail RRP Patient Meeting 2023: Scientific Conference Outcomes and Updates
Related Embedded Video Item Thumbnail Latest Research Findings From the Ongoing NIH RUNX1 Natural History Study
Related Embedded Video Item Thumbnail RRP Patient Meeting 2023: Upcoming Clinical Studies - Dr. Tim Olson

Sign Up For Our Email List!

Enter your information below to receive the
latest RUNX1 news and updates!

Stay In Touch

Email RRP

Newsletter

Policies

Privacy Policy

Cookie Policy

Accessibility Statement

Site Resources

News & Updates

Calendar of Events

RRP Blog

DONATE
SHOP